603087 甘李藥業
按盤價 
79.340 +7.210 (+9.996%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.483 | 5.640 | 3.346 | -4.450 | 15.207 |
| 總資產報酬率 ROA (%) | 5.047 | 5.174 | 3.047 | -4.096 | 14.270 |
| 投入資產回報率 ROIC (%) | 5.442 | 5.597 | 3.318 | -4.406 | 15.039 | 邊際利潤分析 |
| 銷售毛利率 (%) | 76.249 | 74.830 | 73.259 | 76.300 | 89.034 |
| 營業利潤率 (%) | 30.560 | 20.738 | 12.089 | -33.223 | 47.035 |
| 息稅前利潤/營業總收入 (%) | 31.066 | 17.473 | 8.720 | -39.525 | 42.057 |
| 淨利潤/營業總收入 (%) | 29.209 | 20.184 | 13.046 | -25.669 | 40.220 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 79.764 | 60.611 | 98.437 | 88.691 | 93.766 |
| 價值變動淨收益/利潤總額(%) | 10.426 | 34.560 | 14.835 | -1.187 | 5.049 |
| 營業外收支淨額/利潤總額(%) | 8.598 | -0.183 | -2.987 | 2.335 | -0.171 | 償債能力分析 |
| 流動比率 (X) | 5.396 | 4.732 | 7.985 | 6.967 | 14.150 |
| 速動比率 (X) | 3.879 | 3.418 | 6.872 | 6.169 | 12.809 |
| 資產負債率 (%) | 7.683 | 8.208 | 8.301 | 9.628 | 6.321 |
| 帶息債務/全部投入資本 (%) | -0.937 | -0.858 | -1.134 | -1.156 | -0.949 |
| 股東權益/帶息債務 (%) | -10,599.477 | -11,561.713 | -8,756.858 | -8,562.875 | -10,432.315 |
| 股東權益/負債合計 (%) | 1,201.584 | 1,118.369 | 1,104.609 | 938.613 | 1,482.069 |
| 利息保障倍數 (X) | -13.114 | -5.414 | -2.889 | 7.177 | -8.588 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 31.278 | 35.313 | 38.649 | 116.694 | 87.751 |
| 存貨周轉天數 (天) | 397.441 | 449.330 | 389.502 | 576.622 | 520.223 |
| 備註： | 即時報價更新時間為 24/09/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
